Fortunato, Francesca http://orcid.org/0000-0003-0665-5385
Campanozzi, Angelo
Maffei, Gianfranco
Arena, Fabio
Carri, Valeria Delli
Rollo, Tiziana
Lopalco, Pier Luigi
Martinelli, Domenico
Article History
Received: 21 December 2023
Accepted: 24 February 2024
First Online: 7 March 2024
Declarations
:
: The study was conducted in accordance with the Guidelines for Good Clinical Practice and the ethical principles that originate in the Declaration of Helsinki and within the Italian law. Data were obtained as part of routine clinical activity and analyzed anonymously. Informed consent was waived because all data were de-identified.
: Not applicable.
: Pier Luigi Lopalco received research grants, travel support and personal fees as advisory board member and/or speaker from GSK, Moderna, MSD, Novavax, Pfizer, Seqirus and Sanofi. Francesca Fortunato received travel support from MSD, Sanofi and GSK. Domenico Martinelli received personal fees as speaker from Sanofi and travel support from Sanofi and GSK. The other authors declare that they have no competing interests.